Westlake Chemical Partners (NYSE:WLKP) and CTD (OTCMKTS:CTDH) are both small-cap basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.
This is a summary of recent recommendations for Westlake Chemical Partners and CTD, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Westlake Chemical Partners||0||4||3||0||2.43|
Westlake Chemical Partners pays an annual dividend of $1.64 per share and has a dividend yield of 7.0%. CTD does not pay a dividend. Westlake Chemical Partners pays out 95.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Westlake Chemical Partners has increased its dividend for 3 consecutive years.
Insider & Institutional Ownership
45.9% of Westlake Chemical Partners shares are held by institutional investors. 46.0% of CTD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk & Volatility
Westlake Chemical Partners has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Comparatively, CTD has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500.
This table compares Westlake Chemical Partners and CTD’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Westlake Chemical Partners||4.53%||5.49%||3.59%|
Earnings & Valuation
This table compares Westlake Chemical Partners and CTD’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Westlake Chemical Partners||$1.17 billion||0.64||$48.67 million||$1.72||13.59|
|CTD||$1.23 million||49.71||-$3.83 million||N/A||N/A|
Westlake Chemical Partners has higher revenue and earnings than CTD.
Westlake Chemical Partners beats CTD on 11 of the 14 factors compared between the two stocks.
About Westlake Chemical Partners
Westlake Chemical Partners LP operates, acquires, and develops ethylene production facilities and related assets in the United States. The company operates ethylene production facilities, which primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was founded in 2014 and is headquartered in Houston, Texas.
CTD Holdings, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. The company's lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Neimann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. CTD Holdings, Inc. was founded in 1990 and is based in Gainesville, Florida.
Receive News & Ratings for Westlake Chemical Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners and related companies with MarketBeat.com's FREE daily email newsletter.